Gaps in Evidence‐Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease

BACKGROUND: Evidence‐based therapies are generally underused for cardiovascular risk reduction; however, less is known about contemporary patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. METHODS AND RESULTS: Pharmacy and medical claims data from within Anthem were q...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Adam J., Ardissino, Maddalena, Haynes, Kevin, Shambhu, Sonali, Eapen, Zubin J., McGuire, Darren K., Carnicelli, Anthony, Lopes, Renato D., Green, Jennifer B., O’Brien, Emily C., Pagidipati, Neha J., Granger, Christopher B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955303/
https://www.ncbi.nlm.nih.gov/pubmed/33432843
http://dx.doi.org/10.1161/JAHA.120.016835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955303/
https://www.ncbi.nlm.nih.gov/pubmed/33432843
http://dx.doi.org/10.1161/JAHA.120.016835

Ejemplares similares